The DOI matches its Crossref record; 266 of the 266 references it cites were found in a registry or an index.
The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
Open accessAbstract
Epithelial-to-Mesenchymal Transition (EMT) has been shown to be crucial in tumorigenesis where the EMT program enhances metastasis, chemoresistance and tumor stemness. Due to its emerging role as a pivotal driver of tumorigenesis, targeting EMT is of great therapeutic interest in counteracting metastasis and chemoresistance in cancer patients. The hallmark of EMT is the upregulation of N-cadherin followed by the downregulation of E-cadherin, and this process is regulated by a complex network of signaling pathways and transcription factors. In this review, we summarized the recent understanding of the roles of E- and N-cadherins in cancer invasion and metastasis as well as the crosstalk with other signaling pathways involved in EMT. We also highlighted a few natural compounds with potential anti-EMT property and outlined the future directions in the development of novel intervention in human cancer treatments. We have reviewed 287 published papers related to this topic and identified some of the challenges faced in translating the discovery work from bench to bedside.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–266 of 266
Li, J., Chong, T., Wang, Z., Chen, H., LI, H., Cao, J., Zhang, P., & Li, H. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2417 · Cited by 72
Yang, Z., Xie, Q., Chen, Z., Ni, H., Xia, L. P., Zhao, Q., Chen, Z., & Chen, P. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7142 · Cited by 72
Role of p38γ MAPK in regulation of EMT and cancer stem cells
Xu, M., Wang, S., Wang, Y., Wu, H., Frank, J. A., Zhang, Z., & Luo, J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.024 · Cited by 71
Cadherin Adhesion: Mechanisms and Molecular Interactions
Perez, T. D., & Nelson, W. J. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68170-0_1 · Cited by 70
Jolly, M. K., Tripathi, S. C., Somarelli, J. A., Hanash, S., & Levine, H. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12084 · Cited by 70
E‐cadherin's role in development, tissue homeostasis and disease: Insights from mouse models
Schneider, M. R., & Kolligs, F. T. (2014) · BioEssays · doi:10.1002/bies.201400141 · Cited by 68
Luteolin suppresses UVB ‐induced photoageing by targeting JNK1 and p90RSK2
Lim, S. H., Jung, S. K., Byun, S., Lee, E. J., Hwang, J. A., Seo, S. G., Kim, Y. A., Yu, J. G., Lee, K. W., & Lee, H. J. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12050 · Cited by 67
Jiang, P., Xu, C., Chen, L., Chen, A., Wu, X., Zhou, M., Haq, I. U., Mariyam, Z., & Feng, Q. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27117 · Cited by 67
N-cadherin Regulates p38 MAPK Signaling via Association with JNK-associated Leucine Zipper Protein
Ando, K., Uemura, K., Kuzuya, A., Maesako, M., Asada-Utsugi, M., Kubota, M., Aoyagi, N., Yoshioka, K., Okawa, K., Inoue, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158477 · Cited by 66
Aleskandarany, M. A., Negm, O. H., Green, A. R., Ahmed, M. A. H., Nolan, C. C., Tighe, P. J., Ellis, I. O., & Rakha, E. A. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2927-5 · Cited by 66
del Valle, I., Rudloff, S., Carles, A., Li, Y., Liszewska, E., Vogt, R., & Kemler, R. (2013) · Development · doi:10.1242/dev.088690 · Cited by 66
Li, W., Wang, Q., Su, Q., Ma, D., An, C., Ma, L., & Liang, H. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.0009 · Cited by 64
Kumari, M., Purohit, M. P., Patnaik, S., Shukla, Y., Kumar, P., & Gupta, K. C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.06.030 · Cited by 64
Reckamp, K. L., Gardner, B. K., Figlin, R. A., Elashoff, D. A., Krysan, K., Dohadwala, M., Mao, J., Sharma, S. P., Inge, L. J., Rajasekaran, A. K., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181622bef · Cited by 62
Kim, C., Hwang, K.-A., & Choi, K. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.10.016 · Cited by 62
Kim, S., Shin, S., Lee, J. Y., Kim, C., Chung, I., Kang, H., Park, H. R., Park, B.-S., & Kim, I. (2017) · Nutrition and Cancer · doi:10.1080/01635581.2018.1397708 · Cited by 62
N-cadherin antagonists as oncology therapeutics
Blaschuk, O. W. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0039 · Cited by 61
Liu, S., Wang, B., Li, X., Qi, L., & Liang, Y. (2009) · Journal of Separation Science · doi:10.1002/jssc.200800766 · Cited by 60
Arulanandam, R., Vultur, A., Cao, J., Carefoot, E., Elliott, B. E., Truesdell, P. F., Larue, L., Feracci, H., & Raptis, L. H. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0469 · Cited by 60
Avtanski, D. B., Nagalingam, A., Bonner, M. Y., Arbiser, J. L., Saxena, N. K., & Sharma, D. (2015) · Oncotarget · doi:10.18632/oncotarget.4937 · Cited by 59
Lee, G.-A., Hwang, K., & Choi, K. (2016) · Toxins · doi:10.3390/toxins8060162 · Cited by 59
Liu, S., Lee, W., Lai, D., Wu, S., Liu, C.-Y., Tien, H., Chiu, C., Peng, Y., Jan, Y., Chao, T., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.009 · Cited by 57
Di, L., Liu, L., Yan, Y., Fu, R., Li, Y., Xu, Y., Cheng, Y., & Wu, Z. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1130-2 · Cited by 55
N-Cadherin in Neuroblastoma Disease: Expression and Clinical Significance
Lammens, T., Swerts, K., Derycke, L., Craemer, A. D., Brouwer, S. D., Preter, K. D., Roy, N. V., Vandesompele, J., Speleman, F., Philippé, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031206 · Cited by 51
Chiu, C., Tsai, C.-H., Hsieh, M., Tsai, S., Jan, Y., Lin, W., Lai, D., Wu, S., Hsing, H.-Y., Arbiser, J. L., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.026 · Cited by 51
How many cadherins do human endothelial cells express?
Colás-Algora, N., & Millán, J. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2991-9 · Cited by 50
Pan, H.-C., Lai, D., Lan, K., Shen, C.-C., Wu, S., Chiu, C., Wang, K.-B., & Sheu, M. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt243 · Cited by 49
Xu, J., Zhou, J., Dai, H., Liu, F., Li, W., Wang, W., & Guo, F. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1540-5 · Cited by 48
Jiang, G., Xie, W., Wang, H., Du, J., Bai-ping, W., Xu, W., Liu, H., Xiao, P., Liu, Z.-G., Li, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4577 · Cited by 46
Sun, Y. A., Wang, H., Liu, M., Lin, F., & HUA, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2913 · Cited by 45
Chang, X., Ogle, S. A., Schumacher, M. A., Schilling, N. S., Tokhunts, R. A., Orr–Asman, M. A., Miller, M. L., Robbins, D. J., Hollande, F., & Zavros, Y. L. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00512.2009 · Cited by 45
Zou, Y., Zhou, Y., Jin, Y., He, C., Deng, Y., Han, S., Zhou, C., Li, X., Zhou, Y., & Liu, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b04854 · Cited by 43
STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells
Onishi, A., Chen, Q., Humtsoe, J. O., & Kramer, R. H. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.09.018 · Cited by 42
Thievessen, I., Seifert, H.-H., Swiatkowski, S., Florl, A. R., & Schulz, W. A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601031 · Cited by 41
Lv, X., Qiao, X., Su, L., & Chen, S. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.81 · Cited by 41
Rieger‐Christ, K., Hanley, R. S., Lodowsky, C., Bernier, T., Vemulapalli, P., Roth, M., Kim, J., Yee, A. S., Le, S. M., Marie, P. J., et al. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21299 · Cited by 39
Park, S.-Y., Shin, J., & Kee, S. (2017) · Cancer Science · doi:10.1111/cas.13321 · Cited by 39
Zhou, H., Li, G., Huang, S., Feng, Y., & Zhou, A. (2019) · Oncology Letters · doi:10.3892/ol.2019.10387 · Cited by 39
Neill, G. W., Harrison, W. J., Ikram, M. S., Williams, T. D. L., Bianchi, L. S., Nadendla, S. K., Green, J. L., Ghali, L. R., Frischauf, A., O’Toole, E. A., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn037 · Cited by 38
Phase II trial of dacomitinib in patients with HER2-positive gastric cancer
Oh, D., Lee, K.-W., Choi, Y., Kang, W. K., Im, S., Kim, J. W., & Bang, Y. (2015) · Gastric Cancer · doi:10.1007/s10120-015-0567-z · Cited by 38
Zhou, J., Lei, Y., Chen, J., & Zhou, X. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.08.038 · Cited by 38
Cadherins in tissue architecture and disease
Vestweber, D. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1231-5 · Cited by 37
Haÿ, E., Buczkowski, T., Marty, C., Nascimento, S. D., Sonnet, P., & Marie, P. J. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1656 · Cited by 37
Shen, L., Zhang, F., Huang, R., Yan, J., & Shen, B. (2017) · Oncology Letters · doi:10.3892/ol.2017.6665 · Cited by 37
Gonçalves, V. D. P., Ortega, A., Guimarães, M. R., Curylofo‐Zotti, F. A., Rossa, C., Ribeiro, D. A., & Spolidório, L. C. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25035 · Cited by 35
Moshiri, A., Puppo, M., Rossi, M. S., Gherzi, R., & Briata, P. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.01.001 · Cited by 34
Anticancer effects of novel resveratrol analogues on human ovarian cancer cells
Vergara, D., Domenico, S. D., Tinelli, A., Stanca, E., del Mercato, L. L., Giudetti, A. M., Simeone, P., Guazzelli, N., Lessi, M., Manzini, C., et al. (2017) · Molecular BioSystems · doi:10.1039/c7mb00128b · Cited by 34
TGF-β signaling links E-cadherin loss to suppression of nucleotide excision repair
Qiang, L., Shah, P., Barcellos‐Hoff, M. H., & He, Y. Y. (2015) · Oncogene · doi:10.1038/onc.2015.390 · Cited by 33
N-cadherin functions as a growth suppressor in a model of K-ras-induced PanIN
Su, Y., Li, J., Shi, C., Hruban, R. H., & Radice, G. L. (2015) · Oncogene · doi:10.1038/onc.2015.382 · Cited by 32
Sonic Hedgehog Signaling in Thyroid Cancer
Xu, X., Lu, Y., Li, Y., & Prinz, R. A. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00284 · Cited by 32
Ge, R., Wang, Z., Wu, S., Zhuo, Y., Otsetov, A., Cai, C., Zhong, W., Wu, C., & Olumi, A. F. (2015) · Oncotarget · doi:10.18632/oncotarget.5023 · Cited by 30
A novel resveratrol–salinomycin combination sensitizes ER-positive breast cancer cells to apoptosis
Venkatadri, R., Iyer, A. K. V., Kaushik, V., & Azad, N. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.03.024 · Cited by 27
Curcumin increases efficiency of γ-irradiation in gliomas by inhibiting Hedgehog signaling pathway
Meng, X., Cai, J., Liu, J., Han, B. R., Gao, F., Gao, W., Zhang, Y., Zhang, J., Zhao, Z., & Jiang, C. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1320000 · Cited by 27
Al-Qasem, A. J., Al‐Howail, H. A., Al‐Swailem, M., Al‐Mazrou, A., Al‐Otaibi, B., Al‐Jammaz, I., Al‐Khalaf, H. H., & Aboussekhra, A. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22271 · Cited by 26
WWC3 inhibits epithelial–mesenchymal transition of lung cancer by activating Hippo-YAP signaling
Han, Q., Kremerskothen, J., Lin, X., Zhang, X., Rong, X., Zhang, D., & Wang, E. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s162387 · Cited by 26
Classical cadherins control survival through the gp130/Stat3 axis
Geletu, M., Arulanandam, R., Chevalier, S. A., Sáez, B., Larue, L., Feracci, H., & Raptis, L. H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.03.014 · Cited by 25
Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma
Wang, L., Jin, J. Q., Zhou, Y., Tian, Z., Jablons, D. M., & He, B. (2017) · Oncotarget · doi:10.18632/oncotarget.22856 · Cited by 25
Al‐Howail, H. A., Hakami, H., Al‐Otaibi, B., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2583-8 · Cited by 24
Role of phytochemicals in the inhibition of epithelial–mesenchymal transition in cancer metastasis
Kim, E., Choi, E., & Debnath, T. (2016) · Food & Function · doi:10.1039/c6fo00901h · Cited by 23
He, S., Xiang, C., Zhang, Y., Lu, X., Chen, H., & Xiong, L. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s139546 · Cited by 23
Synthesis and Biological Evaluation of Curcumin Analogues
Bukhari, S. N. A., Jantan, I., Jasamai, M., Ahmad, W., & Amjad, M. W. (2013) · Journal of Medical Sciences(Faisalabad) · doi:10.3923/jms.2013.501.513 · Cited by 18
Anticancer Drugs Targeting Tubulin and Microtubules
Avendaño, C., & Menéndez, J. C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-444-52824-7.00008-1 · Cited by 15
Evolution of Cadherins and Associated Catenins
Hulpiau, P., Gül, I. S., & Roy, F. M. V. (2016) · Springer eBooks · doi:10.1007/978-4-431-56033-3_2 · Cited by 12
Gumbiner, B. M. (2016) · Springer eBooks · doi:10.1007/978-4-431-56033-3_3 · Cited by 12
[Advances in studies on absorption, distribution, metabolism of flavonoids].
Lv, P., Huang, X., & Lv, Q.-J. (2007) · PubMed · Cited by 6
(2000) · doi:10.1002/1097-0177(200007)218:3<472::aid-dvdy1008>3.0.co;2-#
Cited by
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Usman, S., Waseem, N. H., Nguyen, T. K. N., Mohsin, S., Jamal, A., Teh, M.-T., & Waseem, A. (2021) · Cancers · doi:10.3390/cancers13194985 · Cited by 430
EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
Pan, G., Liu, Y., Shang, L., Zhou, F., & Yang, S. (2021) · Cancer Communications · doi:10.1002/cac2.12138 · Cited by 362
Datta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., et al. (2021) · Cancers · doi:10.3390/cancers13081882 · Cited by 184
Self-citationTGF-β signaling networks in the tumor microenvironment
Chan, M. K.-K., Chung, J. Y.-F., Tang, P. C.-T., Chan, A. S.-W., Ho, J. Y.-Y., Lin, T. P.-T., Chen, J., Leung, K.-T., To, K.-F., Lan, H.-Y., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215925 · Cited by 90
Metadata
- Authors
- Loh, C.-Y., Chai, J., Tang, T., Wong, W., Sethi, G., Shanmugam, M., Chong, P., & Looi, C.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-09-20
- Volume
- 8
- Issue
- 10
- Pages
- 1118
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2974147039
- Cited by
- 1,315
- References
- 266
- FWCI
- 44.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.